Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms.
about
The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field.Elovanoids are novel cell-specific lipid mediators necessary for neuroprotective signaling for photoreceptor cell integrityCharacterizing the anti-inflammatory and tissue protective actions of a novel Annexin A1 peptide.Pro-Resolving Molecules-New Approaches to Treat Sepsis?New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration.Anti-inflammatory and antioxidative effects of Camellia oleifera Abel components.P450 Eicosanoids and Reactive Oxygen Species Interplay in Brain Injury and Neuroprotection.Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology.Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors.Emerging role of chemoprotective agents in the dynamic shaping of plasma membrane organization.The novel lipid mediator PD1n-3 DPA: An overview of the structural elucidation, synthesis, biosynthesis and bioactions.Polyunsaturated fatty acids and endocannabinoids in health and disease.13-Series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis.Molecular mechanisms of signaling via the docosanoid neuroprotectin D1 for cellular homeostasis and neuroprotection.What makes gouty inflammation so variable?Increased 15-PGDH expression leads to dysregulated resolution responses in stromal cells from patients with chronic tendinopathy.Neuroprotective Effects of Annexin A1 Tripeptide after Deep Hypothermic Circulatory Arrest in Rats.Resolvin D1 Improves the Resolution of Inflammation via Activating NF-κB p50/p50-Mediated Cyclooxygenase-2 Expression in Acute Respiratory Distress Syndrome.Lipoxin A4 encapsulated in PLGA microparticles accelerates wound healing of skin ulcers.Lipid composition of membrane microdomains isolated detergent-free from PUFA supplemented RAW264.7 macrophages.Dietary and Microbial Metabolites in the Regulation of Host Immunity.Pro-Resolving Mediators in Regulating and Conferring Macrophage Function.Rosiglitazone as a Modulator of TLR4 and TLR3 Signaling Pathways in Rat Primary Neurons and Astrocytes.Protective Effects of ω-3 PUFA in Anthracycline-Induced Cardiotoxicity: A Critical Review.Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases.Neutrophils: Beneficial and Harmful Cells in Septic Arthritis.Stereopermutation on the Putative Structure of the Marine Natural Product Mucosin.Early treatment with Resolvin E1 facilitates myocardial recovery from ischaemia in mice.Immune responsive resolvin D1 programs myocardial infarction-induced cardiorenal syndrome in heart failure.Impaired Production and Diurnal Regulation of Vascular RvDn-3 DPA Increases Systemic Inflammation and Cardiovascular Disease.Atherosclerosis, Periodontal Disease, and Treatment with Resolvins.Maresins: Specialized Proresolving Lipid Mediators and Their Potential Role in Inflammatory-Related Diseases.Specialized Pro-resolving Mediators Regulate Alveolar Fluid Clearance during Acute Respiratory Distress Syndrome.Neurocognitive Function after Cardiac Surgery: From Phenotypes to Mechanisms.Lipoxins Regulate the Early Growth Response-1 Network and Reverse Diabetic Kidney Disease.Linkage of Infection to Adverse Systemic Complications: Periodontal Disease, Toll-Like Receptors, and Other Pattern Recognition Systems.Resolvin D1 promotes corneal epithelial wound healing and restoration of mechanical sensation in diabetic mice.The Central Role of the Inflammatory Response in Understanding the Heterogeneity of Sepsis-3.Anti-Inflammatory Effects of Resveratrol: Mechanistic Insights.Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week
P2860
Q30234961-61EE4104-4505-4F8F-A70F-7AABBFED5AC4Q33902944-1D7FEBB6-3304-458B-9B00-CF91141B4C48Q36346110-CB3ABD86-891C-47A2-A20D-8B3FD3C2A4BBQ37728979-D4AAE0E7-BD4D-4611-9E25-D06CBED5570FQ38627502-576C5579-7F0F-4711-9E6E-3B086B1BABA7Q38644797-7564473A-5E44-4922-913B-1C592377D6CBQ38744600-06B0B3B0-340F-429C-90AB-32EE273FBFF8Q39163938-C87E56EB-05C8-4716-83E4-80FE58835236Q39197238-01C0E96F-4DE0-4828-9B7A-21B8E759AB3FQ39200406-72A13A49-BAB8-41BD-BAA8-AF979CE251FAQ39365490-63FF0527-4695-42B1-95E9-C0530FC173DBQ39421016-7F951CF3-23D1-4B62-887A-242B3225E4C5Q40971881-3BEF847B-280A-4C2C-AE8A-D205A67AF75CQ41173599-56C96CE2-3841-4368-8402-337344AFF115Q41451121-742BEB81-186B-44CC-B97A-321A2AE6CAE4Q41479135-EA771E58-9F3E-457C-BCB9-3905252BD88BQ41598783-E6F9ABFA-E1E0-42FF-9B82-7BCB3B9F24A3Q41609633-E29096E1-8509-4F92-87E6-8CABBAC95F4CQ41813359-B6E808DB-B1E4-4AED-B23C-79F7E6169D4FQ46324874-B8301C55-1CA1-4180-A589-7AC3236A53B1Q47094084-1D27F10C-3CD3-48D0-A269-AFFA1FA4815EQ47104000-CBACF329-97E7-4680-B088-19DB251409FCQ47232222-95B20B6B-C3FD-45CC-8810-45C2897CFB8EQ47787078-7F657B6F-23F0-462D-8C48-8C0B69035F75Q47979606-67BD0D02-0E93-4437-ACA0-C8C95E02FEE3Q48104478-8CF1D020-750E-4AD6-96FD-956A5F70A5ADQ48190845-69083F28-3FE6-4830-912D-9B32AE2EFDFEQ48326126-B17E5844-3CDE-45BA-BEBC-EC806D410F0EQ49888772-42BA62D1-BF22-4ECE-B3D9-5E66968AFF11Q50043689-43232049-CB68-4CAF-8EF5-F847283CD869Q50129587-9C0F3575-CEF4-4F8F-98DC-C54F2CF090F0Q52576158-DE371819-1B58-479E-B37F-981A6B04B595Q52583506-E03D8902-9FA5-461A-BEEE-04812614CF26Q52604751-E0EEFF9F-EB80-42FB-B9DB-A04099ED45A0Q52680904-77F5A832-542B-4987-9103-94C391D5E611Q53698113-DED89CEE-B7C1-47E0-8F96-31C821CAE6C6Q54974225-9C056378-E2C2-45B4-B13D-855198673947Q55419461-8748CC8F-355D-4551-B2DC-1E39764A5C60Q55560479-2C0FBFC5-D582-4371-A752-DA4D72BC9393Q57797462-078520D9-FCDE-49FA-BD53-199BAE8D3C83
P2860
Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Treating inflammation and infe ...... tion mediators and mechanisms.
@en
Treating inflammation and infe ...... tion mediators and mechanisms.
@nl
type
label
Treating inflammation and infe ...... tion mediators and mechanisms.
@en
Treating inflammation and infe ...... tion mediators and mechanisms.
@nl
prefLabel
Treating inflammation and infe ...... tion mediators and mechanisms.
@en
Treating inflammation and infe ...... tion mediators and mechanisms.
@nl
P2860
P356
P1433
P1476
Treating inflammation and infe ...... tion mediators and mechanisms.
@en
P2093
Charles N Serhan
P2860
P304
P356
10.1096/FJ.201601222R
P407
P577
2017-01-13T00:00:00Z